Press Release

Leo Lens Pharma Excited to Have Its Lead Asset Ready for Human Clinical Evaluation

Patented product for the novel treatment of glaucoma is IND-ready

Leo Lens Pharma Appoints Dan Myers CEO

Accomplished Ophthalmic Executive to Lead Company in Its Next Phase

Myopia Management Focus of Pipeline Expansion for Leo Lens Pharma

Leo Lens Pharma Strengthens its Pipeline with New IP Protection for a Unique Atropine-based Myopia Management Solution February 19, 2020 08:51 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) announced it received a notice of allowance from the USPTO for a patent for the use […]

Leo Lens Technology Selected as Finalist for Connect’s 2019 Most Innovative New Product Awards

FOR IMMEDIATE RELEASE Leo Lens Technology Selected as Finalist for Connect’s 2019 Most Innovative New Product Awards Unique Drug Delivery Contact Lens Product is a Finalist in the Life Sciences & Healthtech Category SAN DIEGO, CA, USA (NOVEMBER 11, 2019) – Today, Leo Lens Technology announced that its unique drug delivery contact lens product has […]